Acyclic phosphonate nucleotides and human adenylate kinases: Impact of a borano group on α-P position

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 4, 2008, Pages 319-331

  Topalis, D ^a   Alvarez, K ^b   Barral, K ^b   Munier Lehmann, H ^c   Schneider, B ^c   Veron M ^c   Guerreiro, C ^c   Mulard, L ^c   El Amri, C ^a   Canard, B ^b   Deville Bonne, D ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

Adenylate kinase; Borano analogues; Phosphinate; Phosphonate

Indexed keywords

ADEFOVIR; ADENOSINE PHOSPHATE KINASE 1; ADENOSINE PHOSPHATE KINASE 2; ADENYLATE KINASE; BORANE DERIVATIVE; NUCLEOTIDE DERIVATIVE; RECOMBINANT ENZYME; TENOFOVIR; UNCLASSIFIED DRUG;

ARTICLE; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION;

ADENINE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; BINDING SITES; BORANES; CATALYTIC DOMAIN; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; KINETICS; MODELS, MOLECULAR; NUCLEOTIDES; PHOSPHONIC ACIDS; PHOSPHORYLATION; RECOMBINANT PROTEINS; SOMAN;

EID: 42049123099     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770801941952     Document Type: Article

References (31)

1. Meyer, P.; Schneider, B.; Sarfati, S.; Deville-Bonne, D.; Guerreiro, C.; Boretto, J.; Janin, J.; Véron, M.; Canard, B. Structural basis for activation of α-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase. EMBO J. 2000, 19, 3520-3529.
2. Boyle, N.A.; Rajwanshi, V.K.; Prhavc, M.; Wang, G.; Fagan, P.; Chen, F.; Ewing, G.J.; Brooks, J.L.; Hurd, T.; Leeds, J.M.; Bruice, T.W.; Cook, P.D. Synthesis of 2′,3′-dideoxynucleoside 5′-alpha -P-borano-beta, gamma (difluoromethylene)triphosphates and their inhibition of HIV-1 reverse transcriptase. J. Med. Chem. 2005, 48, 2695-2700.
3. Deval, J.; Alvarez, K.; Selmi, B.; Bermond, M.; Boretto, J.; Guerreiro, C.; Mulard, L.; Canard, B. Mechanistic insights into the suppression of drug resistance by human immunodeficiency virus type 1 reverse transcriptase using α-oranophosphate nucleoside analogs. J. Biol. Chem. 2005, 280, 3838-3846.
4. De Clercq, E.; Holy, A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat. Rev. Drug Discov. 2005, 4, 928-940.
5. Votruba, I.; Bernaerts, R.; Sakuma, T.; De Clercq, E.; Merta, A.; Rosenberg, I.; Holy, A. Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis. Mol. Pharmacol. 1987, 32, 524-529.
6. Balzarini, J.; Hao, Z.; Herdewijn, P.; Johns, D.G.; De Clercq, E. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent antihuman immunodeficiency virus compound. Proc. Natl. Acad. Sci. 1991, 88, 1499-1503.
7. Robbins, B.L.; Greenhaw, J.; Connelly, M.C.; Fridland, A. Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl) adenine in human lymphoid cells. Antimicrob. Agents Chemother. 1995, 39, 2304-2308.
8. Morera, S.; Lacombe, M.-L.; Xu, Y.; LeBras, G.; Janin, J. X-ray structure of nm23 human Nucleoside Diphosphate kinase B at 1.8A resolution. Structure 1995, 3, 1307-1314.
9. Filippakopoulos, P.; Bunkoczi, G.; Jansson, A.; Schreurs, A.; Knapp, S.; Edwards, A.; Von Delft, F.; Sundstrom, M. Crystal structure of human AK1A in complex with AP5A. Structural Genomics Consortium Oxford. PDB code 1Z83, 2005.
10. Maughan, D.W.; Henkin, J.A.; Vigoreaux, J.O. Concentrations of glycolytic enzymes and other cytosolic proteins in the diffusible fraction of a vertabrate muscle proteome. Mol. Cell Prot. 2005, 4, 1541-1549.
11. Barral, K.; Priet, S.; Sire, J.; Neyts, J.; Balzarini, B.; Canard, B.; Alvarez, K. Synthesis, in vitro antiviral evaluation and stability studies of novel alpha-borano-nucleotide analogues of 9-(2-(phosphonylmethoxy) ethyl)adenine (PMEA) and (R-9-(2-(phosphonomethoxy)propyl)adenine (PMPA). J. Med. Chem. 2006, 49, 7799-7806.
12. Frangeul, A.; Barral.; Alvarez, K.; Canard, B. In vitro suppression of K65R reverse transcriptase-mediated tenofovir- and adefovir-5′-diphosphate resistance conferred by the boranophosphonate derivatives. Antimicrob. Agents Chemother. 2007, 51, 3162-3167.
13. Sambrook, J.; Fritsch, E.F.; Manniati, S.T. Molecular cloning: A laboratory manual. Cold Spring Harbor: NY, 1989.
14. Sanger, F.; Nicklen, S.; Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977, 74, 5463-5467.
15. Munier, H.; Gilles, A.-M.; Glaser, P.; Krin, P.; Danchin, A.; Sarfati, R.; Barzu, O. Isolation and characterization of catalytic and calmodulin-binding domains of Bordetella pertussis adenylate cyclase. FEBs. J. 1991, 196, 469-474.
16. Blondin, C.; Serina, L.; Wiesmuller, L.; Gilles, A.-M.; Barzu, O. Improved spectrophotometric assay of nucleoside monophosphate kinase activity using the pyruvate kinase/lactate dehydrogenase coupling system. Anal. Biochem. 1994, 220, 219-221.
17. Pasti, C.; Gallois-Montbrun, S.; Munier-Lehmann, H.; Veron, M.; Gilles, A.-M.; Deville-Bonne, D. Reaction of human UMP-CMP kinase with natural and analog substrates. FEBs. J. 2003, 270, 1784-1790.
18. Ayabe, T.; Takenaka, H.; Takenaka, O.; Sumida, M.; Maruyama, H.; Onitsuka, T.; Shibata, K.; Uesugi, S.; Hamada, M. Essential lysine residues in the N-terminal and the C-terminal domain of hyman adenylate kinase interact with adenine nucleotides as found by site-directed random mutagenesis. Biochemistry 1997, 36, 4027-4033.
19. Yan, H.; Tsai, M.-D. Nucleoside monophosphate kinases: structure, mechanism and substrate specificity. Adv. Enzymol. 1999, 73, 103-134.
20. Font, B.; Gautheron, D. General and kinetic properties of pig heart mitochondrial adenylate kinase. Biochem. Biophys. Acta 1980, 611, 299-308.
21. Walker, E.J.; Dow, J.W. Location and properties of two isoenzymes of cardiac adenylate kinase. Biochem. J. 1982, 203, 361-369.
22. Vonrheim, C.; Schlauderer, G.J.; Schulz, G.E. Movie of the structural changes during a catalytic cycle of nucleoside monophosphate kinases. Structure 1995, 3, 483-490.
23. Wolf-Watz, M.; Thai, V.; Henzler-Wildman, K.; Hadjipavlou, G.; Eisenmesser, E.Z.; Kern, D. Linkage between dynamics and catalysis in a thermophilic-mesophilic enzyme pair. Nat. Struc. Mol. Biol. 2004, 11, 945-949.
24. Bae, E.; Phillips, G.N.Jr. Roles of static and dynamic domains in stability and catalysis of adenylate kinase. Proc. Natl. Acad. Sci. 2006, 103, 2132-2137.
25. Tuske, S.; Sarafanios, S.G.; Clark Jr, A.D.; Ding, J.; Naeger, L.K.; White, K.L.; Miller, M.D.; Gibbs, C.S.; Boyer, P.L.; Clark, P.; Wang, G.; Gaffney, B.L.; Jones, R.A.; Jerina, D.M.; Hughes, S.H.; Arnold, E. Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat. Struc. Mol. Biol. 2004, 11, 469-474.
26. Hible, G.; Daalova, P.; Gilles, A.-M.; Cherfils, J. Crystal structures of GMP kinase in complex with ganciclovir monophosphate and Ap5G. Biochimie 2006, 88, 1157-1164.
27. Summers, J.S.; Shaw, B.R. Boranophosphates as mimics of natural phosphodiesters in DNA. Cur. Med. Chem. 2001, 8, 1147-1155.
28. Hutter, M.C.; Helms, V. Phosphoryl transfer by a concerted reaction mechanism in UMP-CMP kinase. Prot. Sci. 2000, 9, 2225-2231.
29. Lavie, A.; Schlichting, I.; Vetter, I.R.; Konrad, M.; Reinstein, J.; Goody, R.S. The bottleneck in AZT activation. Nat. Med. 1997, 3, 922-924.
30. Skoblov, J.S.; Frank-Kamenetskaya, M.D.; Chernov, D.N.; Krayevsky, A.A. Modified nucleotides as substrates and inhibitors of adenylate kinase from different sources. FEBS. Let. 1996, 395, 283-285.
31. Vinogradov, S.V.; Kohli, E.; Zeman, A.D. Cross-linked polymeric nanogel formulations of 5′-triphosphates of nucleosides analogues: role of a cellular membrane in drug release. Mol. Pharmacol. 2005, 2, 449-461.